Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87) [PDF]
Urokinase-type plasminogen activator (uPA) represents a central molecule in pericellular proteolysis and is implicated in a variety of physiological and pathophysiological processes such as tissue remodelling, wound healing, tumor invasion, and ...
Kellermann, Josef +10 more
core +1 more source
Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis [PDF]
Pemphigus is an autoimmune blistering disease of the skin and mucous membranes. It is caused by autoantibodies directed against desmosomes, which are the principal adhesion structures between epidermal keratinocytes.
Besch, R. +19 more
core +2 more sources
Tyrosine phosphorylation of human urokinase‐ type plasminogen activator [PDF]
Immunoblatting analysis of purified human urokinase plasminogen activator (u‐PA), gives a positive signal when reacted with anti‐phosphotyrosine monoclonal antibodies (MoAb anti P‐Tyr); competition with α‐phospha‐DL‐tyrosine (P‐Tyr) but not α‐phosphia‐DL‐threonine or serine (P‐Treo, P‐Ser) completely suppresses this signal.
BARLATI, Sergio +3 more
openaire +3 more sources
Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy
The coronavirus disease 2019 (COVID-19) pandemic requires not only the creation of vaccines to prevent the spread of the disease, but also the development of novel drugs aimed at reducing viral load, suppressing an excessive immune response and ...
K. A. Rubina +5 more
doaj +1 more source
Multiparity upregulates placental plasminogen and urokinase‐type plasminogen activator
ProblemMultiparity increased the number of trophoblast cells in decidua of both low and high fetal loss mouse models. However, they differ in fetal survival rate and maternal thymocyte subpopulations, suggesting that trophoblast invasiveness is not equivalent.
María E. Cortina +3 more
openaire +3 more sources
Proenzyme to urokinase‐type plasminogen activator in the mouse in vivo [PDF]
We have investigated whether urokinase‐type plasminogen activator (u‐PA) is present in the mouse in vivo as the proenzyme or as the active enzyme. u‐PA in extracts of various murine tissues was of a one‐polypeptide chain form with an electrophoretic mobility indistinguishable from purified proenzyme (pro‐u‐PA), as demonstrated by SDS‐polyacrylamide gel
Kielberg, V. +5 more
openaire +2 more sources
Nuclear translocation of urokinase-type plasminogen activator
AbstractUrokinase-type plasminogen activator (uPA) participates in diverse (patho)physiological processes through intracellular signaling events that affect cell adhesion, migration, and proliferation, although the mechanisms by which these occur are only partially understood. Here we report that upon cell binding and internalization, single-chain uPA (
Victoria, Stepanova +12 more
openaire +3 more sources
Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer [PDF]
The association of MMP-2 (matrix metalloproteinase 2, 72-kD collagenase IV) with invasive and metastatic capacity of tumor cells has implicated a potential role in the prognosis for cancer patients.
Beyer, Bianca C. M. +6 more
core +1 more source
The chicken urokinase-type plasminogen activator gene
The chicken urokinase-type plasminogen activator (uPA) cDNA and gene have been isolated and the complete nucleotide sequence of each established. cDNA sequence and Northern blot RNA analysis indicate that the chicken uPA mRNA is approximately 2500 nucleotides in size and contains a large 3'-noncoding region (998 nucleotides).
N D, Leslie +3 more
openaire +2 more sources
Background Astrocytes contribute to the crosstalk that generates chronic neuro-inflammation in neurological diseases; however, compared with microglia, astrocytes respond to a more limited continuum of innate immune system stimulants.
Paola Pontecorvi +8 more
doaj +1 more source

